![](https://scx1.b-cdn.net/csz/news/tmb/2017/wedontneedto.jpg)
We don't need to change how we subsidise 'breakthrough' cancer treatments
New therapies that arm the immune system to fight cancer, such as Keytruda (pembrolizumab) and Yervoy (ipilimumab), have offered patients with advanced melanoma real hope of effective treatment.
Nov 27, 2017
0
1